Royalty Pharma Plc (RPRX)
39.25
-0.14
(-0.36%)
USD |
NASDAQ |
Dec 24, 16:00
Royalty Pharma Market Cap: 16.77B for Dec. 24, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Denali Therapeutics, Inc. | 2.653B |
| Alnylam Pharmaceuticals, Inc. | 52.94B |
| Amgen, Inc. | 179.83B |
| Eli Lilly & Co. | 963.92B |
| Zenas BioPharma, Inc. | 1.806B |
Market Cap Related Metrics
| PE Ratio | 22.45 |
| PS Ratio | 9.557 |
| Price to Book Value | 2.614 |
| Price to Free Cash Flow | 21.43 |
| Price | 39.25 |
| Earnings Yield | 4.46% |
| Operating PE Ratio | 14.66 |
| Normalized PE Ratio | 21.37 |